Herpes Zoster Dermatome Nervus C6-C7 In TB-MDR Patients : Case Report

Authors

  • Mitha Miftahul Jannah Medical Faculty Lampung University
  • Yulisna Medical Faculty Lampung University

Keywords:

Case report, herpes zoster, varisela zoster virus,

Abstract

Herpes shingles (HZ) is an infectious disease caused by the reactivation of the varicella shingles virus (VVZ). Are localized, mainly attacking adults with a characteristic of radicular pain, unilateral, and a horde of vesicles that are dispersed according to dermatoms that are ineralized by a single sensory nerve ganglion. Factors that potentially lead to reactivation are: previous exposure to VVZ (chickenpox, vaccination), age more than 50 years, Immunocompromais state, immunosuppressive drugs, HIV/AIDS, bone marrow transplantation or organ, violence, therapy Long-term steroids, psychological stress, trauma and the act of Distinction. Incidence of HZ in children 0.74 from 1000 person per year. This incidence increased to 2.5 from 1000 people at age 20-50 (adult age), 7, from 1000 people aged more than 60 years (older adult age) and reached 10 from 1000 person per year at the age of 80. Case: reported case of Mrs. P, 55 yo with a diagnosis of herpes shingles with TB MDR with based on anamnesis and physical examination administered therapy acyclovir tab 5x800 mg PO/day for 7 days, Paracetamol tab 3x500 mg PO/day if necessary, powder salicyl 2% applied on the lesions 3x/day and given the drug TB MDR namely Cycloserin, etionamides and moxifloxacin. Conculsion: The patient showed good therapeutic results.

References

Oxman MN, Schmader KE. Varicella and herpes zoster. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editors. Fitzpatrick's dermatology in general medicine. 8th ed. New York: McGraw Hill Companies. 2012. p. 2383-400.

Erdina, Hanny, Hans L, Nurjannah, Sjaiful, Syamsuridjal. 2014. Buku Panduan Herpes Zoster di Indonesia 2014. Badan Penerbit FK-UI.

Schmader K, John W G, C Peter W. The Epidemiological, Clinical, and Pathological Rationale for Herpes Zoster Vaccine. JID 2008: 197.

Cohen J. Herpes Zoster. N Engl J Med 2013; 369: 255-63.

Opstelted W, Just E, Arie K, Theo V. Treatment of Herpes Zoster. Can Fam Physician 2008; 54:573-7.

Dumasari R. Varicella dan Herpes Zoster. Departemen Ilmu Kesehatan Kulit dan Kelamin FK Sumatera Utara. 2008.

Weaver B. Herpes Zoster Overview Natural History and Incidence. J Am Osteopath Assoc. 2009;109 (2); s2-s6.

Deshmukh R, Raut A, Sonone Sawar S, Bharude N, Umarar A.Herpes zoster: a fatal viral disease: A comprehensive review. IJPCBS 2012; 2 (2): 138- 45

Dworkin R, Robert WJ, Judith B, John WG, Myron JL, Miroslav B, dkk. Recommendation for the Management of Herpes Zoster. Clinical Infectious Diseases 2007; 44: S1-26.

Shyang JJ, Yi-Ju C, Ming-Wei L, Yu-Chun C, Tzeng-Ji C, Yu- Lin H, dkk. Epidemiological Features and Cost of Herpes Zoster in Taiwan : a national study 2000-2006. Acta Derm Venereol 2009 ; 89: 612-616.

Handoko RP. Penyakit Virus. Dalam: Djuanda A, Mochtar H, Siti A, penyunting. Ilmu Penyakit Kulit dan Kelamin. Edisi-6. Fakultas Kedokteran Universitas Indonesia. Jakarta. 2009; h. 110-112.

Gnann J, Richard J W. Herpes Zoster. N Engl J Med 2002, vol. 347, no 5.

Whitley RJ, Volpi A, McKendrick M, Wijck A, Oaklander AL. Management of herpes zoster and post-herpetic neuralgia now and in the future. Journal of Clinical Virology 2010; 48 (1): 20-8

Galuzzi KE. Management strategies for herpes zoster and postherpetic neuralgia. J Am Osteopath Assoc 2007; 107 (3): 8-13.

Sahriani HR, Kapantow MG, Pandaleke HE. Profil Herpes zoster di Poliklinik Kulit dan Kelamin RSUP Prof.Dr.R.D.Kandou Manado periode Januari-Desember 2012. e-clinic JIK 2014; 2 (1): 1- 7.

Published

2021-04-30

How to Cite

Mitha Miftahul Jannah, & Yulisna. (2021). Herpes Zoster Dermatome Nervus C6-C7 In TB-MDR Patients : Case Report. Medical Profession Journal of Lampung, 9(4), 662-666. Retrieved from http://journalofmedula.com/index.php/medula/article/view/232

Issue

Section

Artikel